JPS6364405B2 - - Google Patents

Info

Publication number
JPS6364405B2
JPS6364405B2 JP55085789A JP8578980A JPS6364405B2 JP S6364405 B2 JPS6364405 B2 JP S6364405B2 JP 55085789 A JP55085789 A JP 55085789A JP 8578980 A JP8578980 A JP 8578980A JP S6364405 B2 JPS6364405 B2 JP S6364405B2
Authority
JP
Japan
Prior art keywords
compound
group
hydroxyphenyl
decomposition
decarboxylation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55085789A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5711909A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP8578980A priority Critical patent/JPS5711909A/ja
Priority to US06/272,895 priority patent/US4418058A/en
Priority to NZ197414A priority patent/NZ197414A/en
Priority to IE1347/81A priority patent/IE51331B1/en
Priority to GB8118684A priority patent/GB2078737B/en
Priority to NL8102943A priority patent/NL191777C/xx
Priority to NO812090A priority patent/NO156036C/no
Priority to FR8112087A priority patent/FR2484835A1/fr
Priority to IL63136A priority patent/IL63136A/xx
Priority to SE8103904A priority patent/SE460702B/sv
Priority to IT67863/81A priority patent/IT1144812B/it
Priority to DK274981A priority patent/DK158443C/da
Priority to ES503283A priority patent/ES8203887A1/es
Priority to KR1019810002265A priority patent/KR840000693B1/ko
Priority to PT73239A priority patent/PT73239B/pt
Priority to FI811948A priority patent/FI75490C/fi
Priority to ZA814203A priority patent/ZA814203B/xx
Priority to RO104646A priority patent/RO82720B/ro
Priority to AT0278881A priority patent/AT380790B/de
Priority to CH4151/81A priority patent/CH648210A5/de
Priority to AU72097/81A priority patent/AU541627B2/en
Priority to DE19813124592 priority patent/DE3124592A1/de
Priority to GR65316A priority patent/GR75646B/el
Priority to DD81231057A priority patent/DD159879A5/de
Priority to CS814743A priority patent/CS221835B2/cs
Priority to YU1573/81A priority patent/YU44416B/xx
Priority to HU811843A priority patent/HU183494B/hu
Priority to BG052598A priority patent/BG37991A3/xx
Priority to AR285821A priority patent/AR230007A1/es
Priority to BE0/205190A priority patent/BE889351A/fr
Priority to CA000380462A priority patent/CA1164801A/en
Publication of JPS5711909A publication Critical patent/JPS5711909A/ja
Publication of JPS6364405B2 publication Critical patent/JPS6364405B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
JP8578980A 1980-06-23 1980-06-23 Stable freeze-dried preparation of beta-lactam Granted JPS5711909A (en)

Priority Applications (31)

Application Number Priority Date Filing Date Title
JP8578980A JPS5711909A (en) 1980-06-23 1980-06-23 Stable freeze-dried preparation of beta-lactam
US06/272,895 US4418058A (en) 1980-06-23 1981-06-12 Protection of lyophilized betalactams from color formation
NZ197414A NZ197414A (en) 1980-06-23 1981-06-15 Stable preparation of lyophilised beta-lactam antibacterial compound
IE1347/81A IE51331B1 (en) 1980-06-23 1981-06-17 Protection of lyophilized betalactams from colour formation
GB8118684A GB2078737B (en) 1980-06-23 1981-06-17 Protection of arylmalonyl derivatives
NL8102943A NL191777C (nl) 1980-06-23 1981-06-18 Gelyofiliseerd farmaceutisch preparaat met anti-bacteriële werking.
NO812090A NO156036C (no) 1980-06-23 1981-06-19 Fremgangsmaate for fremstilling av et frysetoerket beta-laktamantibiotikumpreparat som er stabilt overfor misfarging og kjemisk nedbryting
FR8112087A FR2484835A1 (fr) 1980-06-23 1981-06-19 Preparations stables de b-lactames antibacteriens lyophilises renfermant un compose de sucre ou d'alcool sucre comme agent de stabilisation
IL63136A IL63136A (en) 1980-06-23 1981-06-21 Stabilized 7beta-(alpha-carboxy-alpha-(p-hydroxyphenyl acetamido) 7alpha-methoxy-3-heterocyclylthiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylic acid alkali metal salt preparations and process for preparing them
SE8103904A SE460702B (sv) 1980-06-23 1981-06-22 Lyofiliserad beredning av en beta-laktam stabiliserad med socker eller sockeralkoholfoerening, samt foerfarande foer dess framstaellning
IT67863/81A IT1144812B (it) 1980-06-23 1981-06-22 Composizione antibatterica liofilizzata a base di beta lattami protetta contro la formazione di colore e procedimento per la sua preparazione
DK274981A DK158443C (da) 1980-06-23 1981-06-22 Fremgangsmaade til stabilisering af et lyophiliseret praeparat indeholdende et alkalimetalsalt af en 7beta-(alfa-carboxy-alfa-arylacetamido)-7alfa-methoxy-3-heterocyklisk thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylsyre
ES503283A ES8203887A1 (es) 1980-06-23 1981-06-22 Un procedimiento para la obtencion de una preparacion esta- ble de un agente antibacteriano de beta-lactama liofilizado
KR1019810002265A KR840000693B1 (ko) 1980-06-23 1981-06-22 β-락탐 화합물의 안정화 동결 건조 제제의 제조방법
PT73239A PT73239B (en) 1980-06-23 1981-06-22 Process for preparing lyophilized betalactams from color formation
FI811948A FI75490C (fi) 1980-06-23 1981-06-22 Foerfarande foer framstaellning av stabiliserad -laktam.
ZA814203A ZA814203B (en) 1980-06-23 1981-06-22 Protection of lyophilized betalactams from color formation
RO104646A RO82720B (ro) 1980-06-23 1981-06-22 Procedeu de stabilizare a unui agent antibacterian liofilizat de beta-lactama
AT0278881A AT380790B (de) 1980-06-23 1981-06-23 Verfahren zum stabilisieren von beta-lactamantibiotika
CH4151/81A CH648210A5 (de) 1980-06-23 1981-06-23 Stabile, lyophilisierte antibakterielle zubereitung auf basis eines beta-lactams.
AU72097/81A AU541627B2 (en) 1980-06-23 1981-06-23 Stabilisation of lyophilised beta-lactams
DE19813124592 DE3124592A1 (de) 1980-06-23 1981-06-23 "gegen blaufaerbung stabilisierte, gefriergetrocknete ss-lactam-antibiotika enthaltende praeparate"
GR65316A GR75646B (forum.php) 1980-06-23 1981-06-23
DD81231057A DD159879A5 (de) 1980-06-23 1981-06-23 Verfahren zur herstellung von gegen blauverfaerbung und chemische zersetzung stabilisierten beta-lactam-antibiotika
CS814743A CS221835B2 (en) 1980-06-23 1981-06-23 Method of stabilization of the lyofilized preparation of the antibacrerially active salt 7beta-/alpha-carboxy-alpha-carboxy-alpha-arylacetamido/7alpha-methoxy3-heterocyclythiomethyl-1-dethia-1-oxa-3-cefem-4-carboxyle acid
YU1573/81A YU44416B (en) 1980-06-23 1981-06-23 Process for the protection of a lyophilized preparation
HU811843A HU183494B (en) 1980-06-23 1981-06-23 Process for the stabilization of a pharmaceutical composition containing liophylized beta-lactam
BG052598A BG37991A3 (en) 1980-06-23 1981-06-23 Method for stabilizing lyophylized preparation containing beta- lactamic antibiotic
AR285821A AR230007A1 (es) 1980-06-23 1981-06-23 Un metodo para proteger una preparacion liofilizada que contiene beta-lactama antibacteriana
BE0/205190A BE889351A (fr) 1980-06-23 1981-06-23 Protection des beta-lactames lyophilises contre l'alteration chromogene
CA000380462A CA1164801A (en) 1980-06-23 1981-06-23 Protection of lyophilized betalactams from color formation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8578980A JPS5711909A (en) 1980-06-23 1980-06-23 Stable freeze-dried preparation of beta-lactam

Publications (2)

Publication Number Publication Date
JPS5711909A JPS5711909A (en) 1982-01-21
JPS6364405B2 true JPS6364405B2 (forum.php) 1988-12-12

Family

ID=13868648

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8578980A Granted JPS5711909A (en) 1980-06-23 1980-06-23 Stable freeze-dried preparation of beta-lactam

Country Status (31)

Country Link
US (1) US4418058A (forum.php)
JP (1) JPS5711909A (forum.php)
KR (1) KR840000693B1 (forum.php)
AR (1) AR230007A1 (forum.php)
AT (1) AT380790B (forum.php)
AU (1) AU541627B2 (forum.php)
BE (1) BE889351A (forum.php)
BG (1) BG37991A3 (forum.php)
CA (1) CA1164801A (forum.php)
CH (1) CH648210A5 (forum.php)
CS (1) CS221835B2 (forum.php)
DD (1) DD159879A5 (forum.php)
DE (1) DE3124592A1 (forum.php)
DK (1) DK158443C (forum.php)
ES (1) ES8203887A1 (forum.php)
FI (1) FI75490C (forum.php)
FR (1) FR2484835A1 (forum.php)
GB (1) GB2078737B (forum.php)
GR (1) GR75646B (forum.php)
HU (1) HU183494B (forum.php)
IE (1) IE51331B1 (forum.php)
IL (1) IL63136A (forum.php)
IT (1) IT1144812B (forum.php)
NL (1) NL191777C (forum.php)
NO (1) NO156036C (forum.php)
NZ (1) NZ197414A (forum.php)
PT (1) PT73239B (forum.php)
RO (1) RO82720B (forum.php)
SE (1) SE460702B (forum.php)
YU (1) YU44416B (forum.php)
ZA (1) ZA814203B (forum.php)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597193A (ja) * 1982-07-02 1984-01-14 Shionogi & Co Ltd マロニルメチル基の異性化方法
JPS6045514A (ja) * 1983-08-22 1985-03-12 Shionogi & Co Ltd 安定な抗菌性凍結乾燥製剤
US4797388A (en) * 1984-05-21 1989-01-10 Cetus Corporation Pharmaceutical compositions with galactitol as carrier
US4891391A (en) * 1985-01-03 1990-01-02 Morton Thiokol, Inc. Compositions containing antimicrobial agents in combination with stabilizers
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones
DE3801179A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierung von cephalosporinderivaten durch trocknung mit einem stabilisator sowie stabile zubereitungsformen mit cephalosporinderivaten
BR0112417A (pt) * 2000-07-13 2003-07-01 Daiichi Seiyaku Co Composições farmacêuticas contendo composto dds
US7378408B2 (en) * 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274991A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
CA2906151A1 (en) 2013-03-15 2014-09-18 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
ES2800603T3 (es) 2013-09-09 2021-01-04 Merck Sharp & Dohme Tratamiento de infecciones con ceftolozano/tazobactam en sujetos con insuficiencia renal
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS532931B2 (forum.php) * 1973-12-05 1978-02-01
US3928592A (en) * 1974-02-22 1975-12-23 Lilly Co Eli Antibiotic pharmaceutical compositions
US3993753A (en) * 1974-08-26 1976-11-23 American Home Products Corporation Anhydrous ampicillin stabilization and resultant compositions
GB1463563A (en) * 1974-10-10 1977-02-02 Beecham Group Ltd Pharmaceutical compositions
JPS5151511A (en) * 1974-10-25 1976-05-07 Tooru Tatsuhara Aminosanseizai no anteikaho
US4180571A (en) * 1976-03-25 1979-12-25 Shionogi & Co., Ltd. Arylmalonamido-1-oxadethiacephalosporins
JPS532931A (en) * 1976-06-30 1978-01-12 Saraya Kk Toilet bowl cleaning method
ZA777493B (en) * 1976-12-17 1978-10-25 Scherico Ltd Improvements in or relating to antibiotic formulations
JPS53104722A (en) * 1977-02-19 1978-09-12 Tsumura Juntendo Kk Production of powder for making herb medicine liquid agent
CA1127450A (en) * 1978-08-26 1982-07-13 Gordon L. Mcglennon Load multiplying mechanisms
US4259485A (en) * 1979-04-24 1981-03-31 Eli Lilly And Company Crystallization process

Also Published As

Publication number Publication date
AU7209781A (en) 1983-01-06
AT380790B (de) 1986-07-10
BG37991A3 (en) 1985-09-16
GR75646B (forum.php) 1984-08-02
FR2484835A1 (fr) 1981-12-24
NL191777C (nl) 1996-08-02
SE460702B (sv) 1989-11-13
SE8103904L (sv) 1981-12-24
ATA278881A (de) 1985-12-15
NO156036C (no) 1987-07-15
YU157381A (en) 1984-10-31
RO82720B (ro) 1984-07-30
DK274981A (da) 1981-12-24
PT73239B (en) 1982-07-22
IE811347L (en) 1981-12-23
CS221835B2 (en) 1983-04-29
NZ197414A (en) 1984-10-19
DK158443B (da) 1990-05-21
NL191777B (nl) 1996-04-01
ES503283A0 (es) 1982-04-01
IT8167863A0 (it) 1981-06-22
RO82720A (ro) 1984-05-23
PT73239A (en) 1981-07-01
US4418058A (en) 1983-11-29
ZA814203B (en) 1982-09-29
ES8203887A1 (es) 1982-04-01
JPS5711909A (en) 1982-01-21
KR840000693B1 (ko) 1984-05-21
FI811948L (fi) 1981-12-24
KR830005848A (ko) 1983-09-14
DE3124592A1 (de) 1982-02-11
DE3124592C2 (forum.php) 1990-12-20
AU541627B2 (en) 1985-01-17
DK158443C (da) 1990-10-08
BE889351A (fr) 1981-10-16
AR230007A1 (es) 1984-02-29
NO156036B (no) 1987-04-06
YU44416B (en) 1990-08-31
DD159879A5 (de) 1983-04-13
CA1164801A (en) 1984-04-03
IE51331B1 (en) 1986-12-10
IT1144812B (it) 1986-10-29
FI75490B (fi) 1988-03-31
FR2484835B1 (forum.php) 1983-07-01
GB2078737A (en) 1982-01-13
IL63136A (en) 1984-07-31
NL8102943A (nl) 1982-01-18
CH648210A5 (de) 1985-03-15
GB2078737B (en) 1984-03-14
NO812090L (no) 1981-12-28
IL63136A0 (en) 1981-09-13
FI75490C (fi) 1988-07-11
HU183494B (en) 1984-05-28

Similar Documents

Publication Publication Date Title
JPS6364405B2 (forum.php)
DK163032B (da) Lyofiliseret antibakterielt praeparat indeholdende 7beta-difluormethylthioacetamido-7alfa-methoxy-3-oe1-(2-hydroxyalkyl)-1h-tetrazol-5-ylaa-thiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylsyrealkalimetalsalt samt fremgangsmaade til fremstilling af praeparatet
US6114313A (en) Pharmaceutical compositions for freeze drying
CA1293445C (en) Cephalosporin injection
FI65069C (fi) Foerfarande foer framstaellning av kristallvattenfri ny-kristallin form av natrium-7-(d-alfa-formyloxi-alfa-fenylacetamido)-3-(1-metyl-1h-tetrazol-5-yltiometyl)-3-cefem-4-karboxylat
JP2022185009A (ja) 安定したアザシチジン含有医薬組成物の製造方法
US4222939A (en) Process for preparing solid sodium amoxycillin
IE44410B1 (en) Amorphous cefazolin
JPS61130223A (ja) 抗菌性凍結乾燥製剤
JP2018177649A (ja) ボルテゾミブを含有する医薬組成物
HK1026366B (en) Pharmaceutical compositions comprising a nucleotide analogue suitable for freeze drying